Advertisement

Topics

Latest "AMAG Pharmaceuticals Announces Further Expansion Maternal Health Portfolio" News Stories

09:24 EST 14th December 2018 | BioPortfolio

Here are the most relevant search results for "AMAG Pharmaceuticals Announces Further Expansion Maternal Health Portfolio" found in our extensive news archives from over 250 global news sources.

More Information about AMAG Pharmaceuticals Announces Further Expansion Maternal Health Portfolio on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about AMAG Pharmaceuticals Announces Further Expansion Maternal Health Portfolio for you to read. Along with our medical data and news we also list AMAG Pharmaceuticals Announces Further Expansion Maternal Health Portfolio Clinical Trials, which are updated daily. BioPortfolio also has a large database of AMAG Pharmaceuticals Announces Further Expansion Maternal Health Portfolio Companies for you to search.

Showing "AMAG Pharmaceuticals Announces Further Expansion Maternal Health Portfolio" News Articles 1–25 of 49,000+

Friday 14th December 2018

UNC REX Healthcare Opens Food Pantry in Partnership with Food Lion and the Food Bank

Access to healthy food proven to help patients with healing when they return home UNC REX Healthcare has opened a new Food Pantry to support patients and their families who struggle with access to healthy food. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005086/en/


Generex Biotechnology Partner Regentys Corporation Receives European Patent Approval for ECMH™ for Treatment of Ulcerative Colitis

Regentys Extracellular Matrix Hydrogel (ECMH™) Advances Regenerative Medicine Approach for Inflammatory Bowel Diseases Generex Biotechnology Corporation (OTCQB:GNBT) announced today that Regentys Corporation (formerly Asana Medical, Inc.), a clinical stage regenerative medicine company contracted to become a subsidiary of Generex, was granted Europea...

Walgreens Launches Flu Index™ for 2018-2019 Season

The fifth seasonal Flu Index kicks off with Brownsville, Texas topping the list for flu activity; it serves as an important reminder to take preventive measures to stay healthy this flu season With holiday travel around the corner and flu activity on the rise in many parts of the country, Walgreens today launched its first Flu Index™ for the 2018-201...


TILT Holdings Strengthens Leadership Team, Appoints Lars Vaule Chief Operating Officer

TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTC: SVVTF), a vertically-integrated infrastructure and technology platform serving the cannabis industry, today announced the appointment of Lars Vaule to the role of Chief Operating Officer, effective immediately. The position requires approval by the CSE. Based at the Comp...

Viewpoints: Voters Weighed In With ‘Hands-Off’ Message About Medicare, Medicaid; Small Tweaks Won’t Help Health Care System

Editorial writers weigh in on these health care topics and others.

Research Roundup: ACOs; Diabetes; Food Allergies; And Medicaid

Each week, KHN compiles a selection of recently released health policy studies and briefs.

Class Action Lawsuit Filed Over Children Who Were Held In Psychiatric Hospitals After They’d Been Cleared By Doctors For Release

“The effects of holding children (beyond medical necessity) are heartbreaking at an individual level and staggering when multiplied among all the children who have been subjected to the practice,” the lawsuit against Tthe Illinois Department of Children and Family Services claims. Other news on mental health comes out of Maryland, New York, Iowa and New Hampshire.

Genetic Tests That Use Multiple Variants To Predict Disease Risk Are Gaining Popularity. But Are They Reliable?

The tests are expanded versions of ones that look at a single DNA mutation to assess the risk of getting common diseases. But many questions still remain, including what to even do with the results if a patient is found to be at higher risk. In other public health news: abortion access, gene-editing, lead in toys, and bullying.

Technology Is Key To Giving Consumers Better Experience Navigating Health Plans, Insurers Say

More than half of people who were given a health care literacy test failed it and that lack of knowledge can translate into stress and frustration as well as high costs overall. Insurers say simplifying the system people use to navigate their plan through technology will help improve user experience overall.

AsiaPacific Regional Anesthesia Disposables Market Outlook to 2025 [Report Updated: 12102018] Prices from USD $5096

AsiaPacific Regional Anesthesia Disposables Market Outlook to 2025SummaryGlobalData's new report, AsiaPacific Regional Anesthesia Disposables Market Outlook to 2025, provides key market data on the AsiaPacific Regional Anesthesia Disposables market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Combined Spinal Epidural Disposab...

Tilray® Invests C$7.5M in Québec-Based Cannabis Producer ROSE Lifescience Inc.

High Park enters into sale, supply, distribution and marketing agreement with ROSE as its exclusive partner in Québec Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis production and distribution, today announced an investment in Québec-based cannabis producer, ROSE LifeScience Inc. (“ROSE”) and an exclusive sale, supply, distribution and ...

Stemtech Launches DermaStem® Advanced Formula

The World’s First All-Natural Stem Cell Facial Serum Stemtech Corporation recently advanced its revolutionary DermaStem skincare product by incorporating innovative and natural skin brightening technology plus other enhancements www.youtube.com/watch?v=--pZUH-Bqao. Ray Carter, Stemtech CEO, commented “our products are so advanced, we vi

Pfizer Initiates Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older

Pfizer Inc. (NYSE:PFE) announced today the initiation of a Phase 3 program for its 20-Valent pneumococcal conjugate vaccine (20vPnC) candidate, PF-06482077, for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults aged 18 years and older. “While the full extent of Prevenar 13 prot...

Manage Complex and Chronic Care Conditions with Community Health Choice

Texans often face crucial health-related decisions without training or guidance. How do we decide when to seek emergency care? What are the warning signs of diabetes? Should we go to a clinic or can we reach someone on the phone? Imagine having a partner or team guide you towards better choices for your situation. Houston-based Community He...

Aridis Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryAridis Pharmaceuticals Inc Aridis is a biopharmaceutical companythat focusses on development of novel, differentiated therapies for infectious diseases. The company's pipeline product uses disruptive platform technology to discover potent human monoclonal antibodies from patients.Its proprietary platform, MabIgXis used to discover potent therapeutic antibodies for any diseases and to genera...

Everybody is clamoring for Merck to spin off its animal health division so what do they do.....dig in. Nice. https://twitter.com/odibro/status/1073546177625448449 …

Everybody is clamoring for Merck to spin off its animal health division so what do they do.....dig in. Nice. https://twitter.com/odibro/status/1073546177625448449 …

$IDRA Presents Clinical Safety and Efficacy Update from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment https://globenewswire.com/news-release

$IDRA Presents Clinical Safety and Efficacy Update from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment https://globenewswire.com/news-release/2018/12/14/1667212/0/en/Idera-Pharmaceuticals-Presents-Clinical-Safety-and-Efficacy-Update-from-the-ILLUMINATE-204-Trial-of-the-Combina

Opinion: I have a genetic disease, and know firsthand how important it is to think about preventing this disease for my family's health. https://buff.ly/2UKp5jW 

Opinion: I have a genetic disease, and know firsthand how important it is to think about preventing this disease for my family's health. https://buff.ly/2UKp5jW 

The Finnish Competition and Consumer Authority has given the final approval for the transaction between Terveystalo and Attendo which is intended to be completed on 28 December 2018

Terveystalo Plc Stock exchange release 14 December 2018 at 13:00 EET Terveystalo signed an agreement on 17 May 2018 to acquire the Finnish healthcare operations of Attendo AB. The Finnish Competition and Consumer Authority (FCCA) has today 14 December 2018 given the final approval decision for the transaction. The Transaction is intended to be completed on 28 December 2018 provide...

Patients With Ventricular Assist Devices Presenting to an ED

A better understanding of the ED presentations of patients with LVADs will assist providers in recognizing and managing adverse events in this population. Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health

$MRK to Acquire Privately Held Antelliq Group for €2.1B. Complements Merck Animal Health Portfolio of Vaccines and Pharmaceuticals https://www.businesswire.com/news/home/20181214005076/en/Merck-Acquire-Privately-Held-Antelliq-Group …

$MRK to Acquire Privately Held Antelliq Group for €2.1B. Complements Merck Animal Health Portfolio of Vaccines and Pharmaceuticals https://www.businesswire.com/news/home/20181214005076/en/Merck-Acquire-Privately-Held-Antelliq-Group …

MEDNAX Announces Completion of $250 Million Accelerated Share Repurchase Program

MEDNAX, Inc. (NYSE: MD), the national medical group specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric physician services, and management services, today announced that it has completed the $250 million accelerated share repurchase (ASR) program previously announced on September 4, 2018. Under the terms of the ...

Merck to Acquire Privately Held Antelliq Group

Establishes Merck Animal Health as a Leader in Emerging Digital Tracking, Traceability and Monitoring Technology Complements Merck Animal Health Portfolio of Vaccines and Pharmaceuticals Merck [NYSE:MRK], known as MSD outside the United States and Canada, and privately held Antelliq Group today announced that the companies have signed a...

Faron Pharmaceuticals says first patient successfully been dosed in the phase I/II MATINS study of Clevegen

The study, being initiated at Helsinki and Oulu University Hospitals in Finland, is a first-in-human open-label phase I/II clinical trial to investigate the safety and efficacy of Clevegen in selected metastatic or inoperable solid tumours

NOXXON Announces Key Findings That NOX-A12 Plus Keytruda Induces an Immune Response and Results in Clinical Benefit for Patients

Findings include stable disease and prolonged time on treatment vs. prior therapy in heavily pretreated metastatic pancreatic and colorectal cancer patients Data supports best-in-class pharmacolog...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks